Enzo Biochem Inc (ENZ.N)
ENZ.N on New York Stock Exchange
6.17USD
12:22pm EDT
6.17USD
12:22pm EDT
Change (% chg)
$0.02 (+0.33%)
$0.02 (+0.33%)
Prev Close
$6.15
$6.15
Open
$6.15
$6.15
Day's High
$6.20
$6.20
Day's Low
$6.15
$6.15
Volume
15,413
15,413
Avg. Vol
55,212
55,212
52-wk High
$12.04
$12.04
52-wk Low
$5.35
$5.35
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Jan '18 | 26.95 | -0.043 |
| Oct | 27.68 | -0.014 | |
| FY 2017 | Jul '17 | 28.17 | 0.002 |
| Apr '17 | 27.09 | -0.002 | |
| Jan '17 | 26.26 | -0.023 | |
| Oct | 26.28 | -0.032 | |
| FY 2016 | Jul '16 | 26.60 | 0.768 |
| Apr '16 | 26.43 | -0.046 | |
| Jan '16 | 24.56 | 0.147 | |
| Oct | 25.18 | 0.096 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-18 | 1 | 27.35 | 27.35 | 27.35 | -- |
| Quarter Ending Apr-18 | 1 | 27.92 | 27.92 | 27.92 | -- |
| Year Ending Jul-18 | 1 | 112.13 | 112.13 | 112.13 | 112.70 |
| Year Ending Jul-19 | 1 | 120.68 | 120.68 | 120.68 | -- |
| Earnings (per share) | |||||
| Quarter Ending Jan-18 | 1 | -0.01 | -0.01 | -0.01 | -- |
| Quarter Ending Apr-18 | 1 | -0.02 | -0.02 | -0.02 | -- |
| Year Ending Jul-18 | 1 | -0.09 | -0.09 | -0.09 | -0.11 |
| Year Ending Jul-19 | 1 | 0.02 | 0.02 | 0.02 | -- |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 27.73 | 33.50 | |
| P/E High - Last 5 Yrs. | 7.17 | 120.65 | 46.07 | |
| P/E Low - Last 5 Yrs. | 7.17 | 24.25 | 24.95 | |
| Beta | 1.09 | 0.51 | 0.80 | |
| Price to Sales (TTM) | 2.63 | 17.59 | 7.25 | |
| Price to Book (MRQ) | 3.28 | 3.73 | 5.09 | |
| Price to Tangible Book (MRQ) | 3.70 | 5.85 | 6.62 | |
| Price to Cash Flow (TTM) | 429.50 | 90.36 | 25.50 | |
| % Owned Institutions | 69.43 | 4.53 | 2.24 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 0.92 | 1.53 | |
| Dividend Yield - 5 Year Avg | -- | 0.76 | 0.75 | |
| Dividend 5 Year Growth Rate | -- | 7.01 | 3.92 | |
| Payout Ratio(TTM) | -- | 15.20 | 20.54 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 2.64 | 7.35 | 8.68 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 4.08 | 9.84 | 11.19 | |
| Sales - 5 Yr. Growth Rate | 0.90 | 12.45 | 8.22 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | -87.38 | -2.47 | 22.73 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -108.36 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 8.07 | 10.28 | |
| Capital Spending - 5 Yr. Growth Rate | 5.15 | 18.56 | 10.41 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 4.13 | 4.88 | 2.53 |
| Current Ratio (MRQ) | 4.51 | 5.07 | 3.61 |
| LT Debt to Equity (MRQ) | 0.56 | 42.55 | 11.39 |
| Total Debt to Equity (MRQ) | 0.83 | 49.65 | 14.02 |
| Interest Coverage (TTM) | -9.17 | -26.75 | 39.28 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 43.82 | 38.50 | 54.05 | |
| Gross Margin - 5 Yr. Avg. | 43.65 | 40.12 | 52.18 | |
| EBITD Margin (TTM) | 1.73 | -- | -- | |
| EBITD - 5 Yr. Avg | -1.77 | 5.99 | 15.90 | |
| Operating Margin (TTM) | -4.05 | 5.75 | 4.09 | |
| Operating Margin - 5 Yr. Avg. | 2.73 | -2.68 | 11.23 | |
| Pre-Tax Margin (TTM) | -2.37 | 8.28 | 4.81 | |
| Pre-Tax Margin - 5 Yr. Avg. | 2.60 | 3.04 | 11.54 | |
| Net Profit Margin (TTM) | -2.38 | 5.50 | 1.42 | |
| Net Profit Margin - 5 Yr. Avg. | 2.47 | 0.47 | 7.87 | |
| Effective Tax Rate (TTM) | -- | 533.82 | 30.96 | |
| Effective Tax Rate - 5 Yr. Avg. | 5.13 | 39.47 | 24.26 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 253,783 | 5,655,645 | 813,295,447 | |
| Net Income/Employee (TTM) | -6,046 | -495,209 | 95,590,786 | |
| Receivable Turnover (TTM) | 7.25 | 6.41 | 5.56 | |
| Inventory Turnover (TTM) | 8.46 | 51.05 | 3.44 | |
| Asset Turnover (TTM) | 1.02 | 0.47 | 0.89 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -2.44 | 4.76 | 10.51 | |
| Return on Assets - 5 Yr. Avg. | 3.13 | 6.24 | 11.54 | |
| Return on Investment (TTM) | -2.95 | 5.93 | 13.17 | |
| Return on Investment - 5 Yr. Avg. | 4.38 | 7.81 | 14.94 | |
| Return on Equity (TTM) | -2.98 | 8.74 | 14.98 | |
| Return on Equity - 5 Yr. Avg. | 4.51 | 11.33 | 16.23 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 4.90 | 3.96 | 0.90 |
| EPS (TTM) % | -105.56 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Enzo Biochem Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | -0.32 | -0.20 | 99 | 42 |
| 13 Week | -20.65 | -17.89 | 53 | 77 |
| 26 Week | -37.37 | -40.78 | 35 | 47 |
| 52 Week | -27.82 | -37.58 | 67 | 23 |
| YTD | -24.54 | -25.52 | 40 | 61 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
- BRIEF-Enzo Biochem Reports Q2 Adjusted Loss Per Share $0.04
- BRIEF-Austock Group Says Enzo Silverii Retires As Chief Financial Officer
- BRIEF-Enzo Biochem Q1 Non-GAAP Loss Per Share $0.01
- BRIEF-Enzo Biochem announces NYS department of health's approval of a new women's health infectious disease panel
Institutional Holders
| % Shares Owned: | 69.36% |
| # of Holders: | 153 |
| Total Shares Held: | 32,549,904 |
| 3 Mo. Net Change: | -39,265 |
| # New Positions: | 1 |
| # Closed Positions: | 4 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 10 |
| # Net Buyers: | -5 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.